News
Director's Dealings
8 April 2014
TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, announces that, it was notified today that, on 7 April 2014, Mr Alan Reade and his wife, Mrs Alyson Reade, sold 202,500 Common shares of US$0.001 per share (AIM: TYR) ("TyraTech shares"); at a price of 11.80 pence per TyraTech share.
Mr & Mrs Reade then immediately repurchased 197,500 Common shares at 11.82 pence per TyraTech share; these shares being acquired equally into their respective ISA accounts.
Following these transactions, Alan Reade's beneficial interest in the Company has reduced by 5,000 TyraTech shares to 12,481,358 TyraTech shares representing approximately 6.09% of the Company's issued share capital.
For further information please contact:
| TyraTech Inc. Alan Reade, Non-Executive Chairman Bruno Jactel, Chief Executive Officer |
Tel: +44 7841978709 Tel: +1 919 415 4340 |
| SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44203 368 3551 |
| Allenby Capital Limited , Joint Broker Chris Crawford |
Tel: +44 20 3328 5656 |
| Whitman Howard Limited, Joint Broker Ranald Mc-Gregor Smith / Niall Devins |
Tel: +44 20 7087 4555 |
| Walbrook, Financial PR and IR Bob Huxford /Guy McDougall (Public Relations) Paul Cornelius (Investor Relations) |
Tel: +44 20 7933 8792 Tel: +44 20 7933 8794 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.